LGPD

Privacy Policy — Brazil

Last updated: 24 March 2026 · Effective date: 24 March 2026

Table of Contents

  1. Who We Are
  2. Scope and Applicability
  3. What Data We Collect
  4. Sensitive Health Data
  5. Legal Basis for Processing
  6. How We Use Your Data
  7. International Data Transfers
  8. Data Storage and Security
  9. Data Retention
  10. Third Parties and Data Sharing
  11. AI Processing
  12. Your Rights
  13. Cookies and Local Storage
  14. Children's Data
  15. Changes to This Policy
  16. Contact and Complaints

1. Who We Are

The Fractal Resonance Model platform ("FRM", "we", "us", "our") is operated by Neuro-Medtech UK Ltd, a company registered in England and Wales. We act as the Controller (controlador) of your personal data as defined under Brazil's Lei Geral de Proteção de Dados (LGPD, Lei nº 13.709/2018).

In accordance with LGPD Article 41, an Encarregado (Data Protection Officer) will be appointed and their contact details published on this page once designated. In the interim, privacy enquiries may be directed to our general contact below.

The LGPD applies to our processing activities pursuant to Article 3, as we process personal data of individuals located in Brazil, the processing is carried out for the purpose of offering services to individuals in Brazil, and the personal data was collected in Brazilian territory.

Data Controller (Controlador): Neuro-Medtech UK Ltd
3 Janson Court, Reading, RG1 6NA, United Kingdom
Phone: +44 7402 802288

Encarregado (DPO): To be appointed per LGPD Art. 41

2. Scope and Applicability

This privacy policy applies specifically to the processing of personal data of individuals located in Brazil, in accordance with LGPD Article 3. The LGPD applies when:

This policy should be read alongside our general privacy practices. Where there is a conflict between this policy and local Brazilian law, the provisions that afford greater protection to the data subject (titular) shall prevail.

3. What Data We Collect

We collect and process the following categories of personal data, classified under LGPD Article 5:

Personal Data (Dados Pessoais — Art. 5, I)

Sensitive Personal Data (Dados Pessoais Sensíveis — Art. 5, II)

4. Sensitive Health Data

EEG recordings and neurological analysis results are classified as sensitive personal data (dados pessoais sensíveis) under LGPD Article 5, II. The LGPD imposes stricter requirements for processing such data under Article 11.

We process sensitive health data under the following legal bases:

Under LGPD Article 11, §4, the use of sensitive health data for the purpose of obtaining economic advantage by third parties is prohibited, except in cases of health service provision, pharmaceutical assistance, and health assistance, including ancillary diagnostic and therapeutic services.

5. Legal Basis for Processing

Under the LGPD, every processing activity must have a valid legal basis. Below is a summary of the bases we rely on:

Purpose Legal Basis (LGPD) Article
Account creation and authentication Performance of contract Art. 7, V
Clinical qEEG analysis and reporting Explicit consent (sensitive data) Art. 11, I
Health protection by professionals Health protection Art. 11, II(f)
Platform security and audit logs Legitimate interest Art. 7, IX
Legal and regulatory compliance Legal or regulatory obligation Art. 7, II
Scientific and clinical research Research by research bodies Art. 11, II(c) / Art. 13

6. How We Use Your Data

We use your personal data for the following purposes, always in accordance with the principles of LGPD Article 6 (purpose, adequacy, necessity, transparency, security, non-discrimination, and accountability):

7. International Data Transfers

As Neuro-Medtech UK Ltd is based in the United Kingdom, personal data of Brazilian data subjects is transferred internationally. The LGPD regulates international transfers under Articles 33 to 36.

We rely on the following mechanisms to ensure adequate protection for international transfers:

You have the right to be informed about international transfers and the safeguards applied. We will notify you of any material changes to our transfer mechanisms.

8. Data Storage and Security

In accordance with LGPD Articles 46 and 47, we implement administrative, technical, and organisational security measures to protect personal data against unauthorised access, accidental or unlawful destruction, loss, alteration, communication, or any form of improper or unlawful processing.

Technical Measures

Incident Response

In the event of a security incident that may cause relevant risk or damage to data subjects, we will notify the ANPD and the affected data subjects within a reasonable time, in accordance with LGPD Article 48. The notification will include:

9. Data Retention

Under LGPD Articles 15 and 16, personal data must be deleted after the end of its processing period, except where retention is required by law or regulation. Brazilian medical records are subject to CFM (Conselho Federal de Medicina) Resolution 1.821/2007, which establishes a minimum retention period of 20 years.

Data Category Retention Period Legal Basis
Clinical/qEEG records 20 years minimum CFM Resolution 1.821/2007
Account data Duration of account + 5 years Art. 16, I (legal obligation)
Audit logs 10 years Art. 16, I (regulatory compliance)
Anonymised research data Indefinite Art. 12 (not personal data)
Consent records Duration of processing + 5 years Art. 8, §2 (burden of proof)

Upon termination of processing, data will be deleted or anonymised, unless retention is authorised under LGPD Article 16 for legal compliance, research (with anonymisation), transfer to third parties (with adequate safeguards), or the exclusive use of the controller in anonymised form.

10. Third Parties and Data Sharing

In accordance with LGPD Articles 26 and 27, we may share personal data with the following categories of recipients:

We do not sell personal data. We do not share personal data for direct marketing purposes. All data sharing is subject to the principles of purpose, adequacy, and necessity (LGPD Art. 6).

11. AI Processing

The FRM platform uses computational algorithms and AI-assisted analysis for qEEG interpretation. Under LGPD Article 20, you have the right to request a review of decisions made solely on the basis of automated processing that affect your interests.

Important clarifications about our AI processing:

Per LGPD Article 20, §1, if we cannot provide the information due to trade secrets, the ANPD may conduct an audit to verify any discriminatory aspects in automated processing.

12. Your Rights

Under LGPD Article 18, you (as the data subject / titular) have the following rights, which may be exercised at any time by contacting us:

  1. Confirmation of the existence of processing (Art. 18, I)
  2. Access to your personal data (Art. 18, II)
  3. Correction of incomplete, inaccurate, or out-of-date data (Art. 18, III)
  4. Anonymisation, blocking, or deletion of unnecessary or excessive data, or data processed in non-compliance with the LGPD (Art. 18, IV)
  5. Data portability to another service or product provider (Art. 18, V)
  6. Deletion of data processed with consent, except where retention is legally required (Art. 18, VI)
  7. Information about public and private entities with which your data has been shared (Art. 18, VII)
  8. Information about the possibility of denying consent and the consequences thereof (Art. 18, VIII)
  9. Revocation of consent (Art. 18, IX)

Automated Decision Review

Under LGPD Article 20, you also have the right to request a review of decisions made solely on the basis of automated processing of personal data that affect your interests, including decisions intended to define your personal, professional, consumer, or credit profile, or aspects of your personality.

Right to Petition the ANPD

Under LGPD Article 18, §1, you have the right to file a complaint with the Autoridade Nacional de Proteção de Dados (ANPD) if you believe your data protection rights have been violated.

13. Cookies and Local Storage

The FRM platform uses only essential, functional cookies and browser local storage required for the application to operate. We do not use tracking cookies, advertising cookies, or third-party analytics.

Data stored locally in your browser includes:

This use of cookies and local storage is consistent with the Marco Civil da Internet (Lei 12.965/2014), which governs internet use in Brazil, and the LGPD principles of necessity and purpose limitation.

14. Children's Data

Under LGPD Article 14, the processing of personal data of children and adolescents must be carried out in their best interest.

For patients under 18 years of age:

The best interest of the child or adolescent will always be the primary consideration in any processing decision involving their personal data, in accordance with LGPD Article 14 and the Estatuto da Criança e do Adolescente (ECA, Lei 8.069/1990).

15. Changes to This Policy

We may update this privacy policy from time to time to reflect changes in our practices, legal requirements, or ANPD guidance. When we make material changes:

We encourage you to review this policy periodically to stay informed about how we protect your data.

16. Contact and Complaints

To exercise any of your rights under the LGPD, or for any questions about this privacy policy, you may contact us through the following channels:

Data Controller (Controlador):
Neuro-Medtech UK Ltd
3 Janson Court, Reading, RG1 6NA, United Kingdom
Phone: +44 7402 802288

Encarregado (Data Protection Officer):
To be appointed per LGPD Art. 41
Contact details will be published here once designated.

Filing a Complaint with the ANPD

If you believe your data protection rights have been violated, you have the right to file a complaint with the Autoridade Nacional de Proteção de Dados (ANPD):

Autoridade Nacional de Proteção de Dados (ANPD)
Website: www.gov.br/anpd
Setor Comercial Norte, Quadra 6, Conjunto A, Bloco A, 2º andar
Edifício Venâncio 3.000
CEP 70716-900 — Brasília/DF, Brazil